Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


QUOTED. 10 October 2019. Mark Leahey.

Executive Summary

The Medical Device Manufacturers Association has advised the US Medicare agency to consult closely with orthopedic societies before finalizing a proposal to permit outpatient facilities and ambulatory surgery centers from performing knee and hip procedures. See what MDMA president and CEO Mark Leahey said about it here.

“MDMA recommends that CMS consult closely with surgeons and their representative organizations regarding the clinical suitability of both of these proposals. It is imperative that surgeons continue to have the option to select the appropriate [surgical] setting.” – Mark Leahey, president and CEO, Medical Device Manufacturers Association (MDMA)

Click here for a free trial of Medtech Insight


Related Content





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts